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Given the limited resources available to address conservation problems, decision-makers are 40 
increasingly seeking management solutions that provide value for money. Despite an increasing 41 
number of studies that generate estimates of the return-on-investment from conservation 42 
management interventions, the ways in which costs are reported are highly variable and generally 43 
aggregated. This prevents comparison between studies and the application of systematic tools to 44 
synthesize conservation evidence and evaluate the factors that modify costs and benefits. A 45 
standardized consensus on the type of cost data to collect and report in conservation science would 46 
help build a body of evidence to support decision makers. In efforts to improve evidence-informed 47 
decision-making, conservation has looked to health care for tools to support the integration of 48 
evidence into management decisions. Increasingly, health care uses economic evaluations of 49 
treatment options to estimate the return on investment from medical interventions. Here, we 50 
describe economic evaluations as a tool for evidence-informed decision-making in health care and 51 
draw parallels for how these evaluations could be integrated into conservation. We also suggest 52 
tools to help systematically report economic costs of conservation interventions, and illustrate this 53 
approach with a case study of turtle conservation. We describe the important elements of economic 54 
evaluations, and how these data can be used to greatest effect through tools for evidence synthesis, 55 
such as systematic reviews or synopses, to enable decision-makers to identify cost-effective 56 
interventions. We believe that a routine commitment from researchers to capture the costs of 57 
management interventions would help support evidence-informed decision-making by facilitating 58 
the economic evaluations that support cost-effective management decisions. However, this will 59 
require clear guidelines for how to capture these data and incentives for conducting the necessary 60 
economic evaluations. Being able to present results systematically as return-on-investment could be 61 
an important step in encouraging greater use of science by those making management decisions.  62 
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1. Introduction 63 
The value of testing the effectiveness of potential conservation interventions is now widely 64 
acknowledged. Efforts to synthesize the best available evidence and disseminate it to environmental 65 
managers have grown significantly with the support of tools, such as systematic reviews (Pullin and 66 
Stewart 2006), evidence synopses (Dicks et al. 2014), causal criteria analysis (Norris et al. 2012) and 67 
stand-alone meta-analyses (e.g., Cadotte et al. 2012). Providing decision-makers with the evidence 68 
for the effectiveness of potential management interventions is important, but by itself may not be 69 
sufficient (Cook et al. 2013). Constraints on decision-makers, including resource shortages (James et 70 
al. 2001; Murdoch et al. 2007) and competing priorities (Sheil 2001), mean they must seek the most 71 
cost-effective strategies to achieve their management objectives. The distinction between the most 72 
effective and the most cost-effective management intervention is important because it may lead to 73 
different actions. For example, the most effective weed management option for Rhododendron 74 
ponticum (physical removal followed by herbicide application) is twice as effective as the alternative 75 
(e.g., herbicide application alone) (Tyler et al. 2006). However, the cost of labour means that physical 76 
removal is three times as expensive as herbicide application alone (Tyler et al. 2006) resulting in the 77 
less effective alternative providing a greater return-on-investment. Documenting the costs and 78 
outcomes of common conservation interventions can also reveal where widely used interventions 79 
are wasting resources (e.g., Walsh et al. 2012), with significant implications for policy and practice. 80 
More efficient conservation outcomes are forecast when the costs of management alternatives are 81 
explicitly considered (e.g., Moore et al. 2004; Naidoo et al. 2006; Polasky et al. 2001). These benefits 82 
hold whether considering the heterogeneity of costs to prioritise different actions (e.g., priority 83 
threat management; Chadès et al. 2015, Carwardine et al. 2012) or the spatial heterogeneity of costs 84 
(e.g., systematic conservation planning; Balmford et al. 2000). These and other studies have 85 
increased the emphasis on economic considerations in conservation and translated into more 86 
studies attempting robust cost-effectiveness analysis of conservation interventions (e.g., Gjertsen et 87 
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al. 2014; Murdoch et al. 2007; Kubasiewicz et al. 2016), albeit from a very low base (Fig. 1). Many 88 
studies must base cost estimates on coarse proxies (e.g., Armsworth 2014) or use estimates from 89 
managers because data on actual cost and benefits are not available (e.g., Chadès et al. 2015; 90 
Carwardine et al. 2012). Where actual costs are reported, the details and level of aggregation vary 91 
dramatically. This large heterogeneity prevents comparisons between studies and precludes the use 92 
of methods for evidence synthesis (e.g., systematic reviews or meta-analyses), which could draw 93 
conclusions from the evidence base as a whole. A widespread, systematic reporting of conservation 94 
intervention costs would enable a significant advance in conservation evidence, providing decision-95 
makers with a critical piece of the puzzle for determining how to act. 96 
For more than a decade, conservation has been looking to health care for guidance on how to 97 
improve evidence-informed decision-making (Pullin and Knight 2001; Sutherland et al. 2004). 98 
Pressure from governments to be accountable for the cost-effective use of public funds and the 99 
strategic allocation of finite resources has led to ‘evidence-based medicine’ identifying techniques to 100 
measure the return-on-investment from medical interventions (Brunetti et al. 2013). Despite 101 
adopting many lessons from health care (Dicks et al. 2014; Pullin and Stewart 2006), at present, 102 
conservation lags well behind health care in reporting economic data and incorporating it into the 103 
evaluation of potential management interventions (Cook et al. 2013). 104 
In this article we introduce economic evaluations as an underutilised and a critical tool for evidence-105 
informed decision-making. We highlight the important features of rigorous economic evaluations by 106 
drawing parallels between conservation and health care, and describe the critical metadata studies 107 
must report to ensure they can be interpreted by others. Reporting standards for costs that assist 108 
conservation scientists and practitioners to systematically capture the economic costs of 109 
conservation interventions are currently lacking in conservation. Therefore, we adapt a reporting 110 
protocol used by the World Health Organisation and illustrate its use with a published case study of 111 
Pacific leatherback turtle (Dermochelys coriacea) conservation (Gjertsen et al. 2014). This is, to our 112 
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knowledge, the first available cost reporting protocol for conservation interventions to support cost-113 
effectiveness estimation. We also illustrate how evidence-informed conservation can take the 114 
critical step of integrating economics evaluations into evidence synthesis, a current omission from 115 
conservation evidence, to build a robust evidence base for decision makers. Through more 116 
consistent reporting of costs, conservation science can build an evidence base that enables 117 
conservation decision-makers to identify interventions that provide the greatest return-on-118 
investment. 119 
2. Economic evaluations 120 
2.1. Types of economic evaluations 121 
Methods for collecting data on the costs and outcomes of interventions are termed economic 122 
evaluations (Drummond et al. 2005). Economic evaluations determine the return-on-investment for 123 
different interventions (Shemilt et al. 2008). There are several forms of economic evaluations that 124 
use different approaches to help assess return-on-investment (Samuelson and Nordhaus 2005), 125 
including cost-benefit analysis (CBA) and cost-effectiveness analysis (CEA). 126 
Cost-benefit analysis (CBA) is an approach to economic evaluation that uses monetary units to 127 
compare both the costs of an intervention and its outcomes (Hughey et al. 2003). Using monetary 128 
units to represent both costs and outcomes allows different interventions to be compared 129 
regardless of the types of benefits they provide. Estimating the monetary value of the outcomes of 130 
medical treatments can be highly subjective (e.g. measuring reduction in pain; Robinson-Papp et al. 131 
2015) and it can be similarly challenging to monetise conservation outcomes (Laycock et al. 2009). 132 
The growing fields of environmental accounting and ecosystem services valuation continue to 133 
grapple with processes to place a dollar value on biodiversity and ecosystem services (Häyhä and 134 
Franzese 2014). Estimates are often based on asking people what they would be willing to pay (a 135 
type of contingent valuation) to conserve a conservation target (e.g., a hectare of Amazon rainforest; 136 
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Horton et al. 2003). Even when there are quantifiable, monetary benefits from natural systems, such 137 
as in the case of ecosystem services (e.g., carbon sequestration), there is still no consensus on how 138 
to estimate the monetary value of biodiversity (Häyhä and Franzese 2014).  139 
CEA considers the costs of an intervention in monetary units and the outcomes in relation to the 140 
objective for the intervention (i.e., natural units; Hughey et al. 2003). This allows an assessment of 141 
whether the desired outcomes can be achieved given a particular level of investment. Traditionally, 142 
CEA uses a single measure of outcomes. For example, in health care, CEA might use a single clinical 143 
outcome measure, such as the number of heart-attacks avoided (Brunetti et al. 2013). However, a 144 
more sophisticated type of CEA (sometimes called cost-utility analysis) uses a composite measure of 145 
outcomes. In health care, the composite measures for the value of an intervention are Quality 146 
Adjusted Life Years (QALYs), which measure the increase in patient survival (number of additional 147 
years) along with a measure of their quality of life (Shemilt et al. 2008) and Disability Adjusted Life 148 
Years (DALYs), which measure the number of years lived with disability and years lost due to 149 
premature death (Murray 1994).  150 
A key difference between health care and conservation is that conservation lacks a universally 151 
agreed outcome metric that would provide an equivalent to QALYs and DALYs. Conservation studies 152 
generally use single outcome measures in CEA, such as the number of species or the area of habitat 153 
protected. There have been some attempts to use multiple outcome measures for priority threat 154 
management (Chadès et al. 2015). Where the measures of observed outcomes are in the same units 155 
(e.g., numbers of Pacific leatherback turtle, Dermochelys coriacea), CEA can be used to compare the 156 
return-on-investment provided by different interventions. However, where the outcomes of 157 
interventions are measured using different units (e.g., numbers of Pacific leatherback turtle, D. 158 
coriacea, versus golden eagles, Aquila chrysaetos) CEA cannot meaningfully evaluate different 159 
alternatives (Hockley 2010; Kubasiewicz et al. 2016). A great strength of using agreed, composite 160 
measures of outcomes is that this facilitates a fair comparison of the return-on-investment from 161 
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different interventions that might yield different ecological outcomes. Although, the fact that social 162 
values for different species vary can still complicate comparisons. CEA using a common metric has 163 
occasionally been applied in conservation (Cullen et al. 2001; Cullen et al. 2005; Gjertsen et al. 2014). 164 
Where a common metric is available, it is possible to avoid the challenge of estimating the monetary 165 
value of conservation outcomes (Hockley 2010).  166 
While conservation studies often simplify cost-effectiveness to benefits (conservation gains) divided 167 
by costs (e.g., Carwardine et al. 2012), CEAs are typically conducted by calculating cost-effectiveness 168 
ratios (CER): the intervention costs (IC) minus the avoided costs (AC) divided by the change in 169 
outcomes as the result of the intervention (the “benefits” in the conservation literature ∆O). An 170 
example from public health would be the cost of implementing insecticide-treated bednets to 171 
prevent malaria (e.g., Goodman et al. 2001) where IC would be the costs of buying the bednets and 172 
training the households, AC would be the reduction of costs due to fewer hospital visits and less 173 
work absenteeism and ∆O would be the net reduction in number of malaria cases, deaths or 174 
equivalent health metrics like DALYs. If CER is lower than a threshold, typically associated with the 175 
gross national income per capita or gross domestic product per capita in the country where the 176 
intervention occurs, the project is deemed cost-effective (Sachs 2001).  177 
Estimating AC (i.e., benefits) of an intervention together with the intervention costs at different 178 
scales is an important part of calculating the CER because AC can be larger than IC (i.e. CER<0), 179 
meaning the project is cost-saving (e.g. tackling unhealthy diets by increasing population awareness 180 
is a cost-saving health intervention (Cecchini et al. 2010). For example, the benefits obtained at the 181 
national and global level through the Ranomafana National Park in Madagascar were greater than 182 
the opportunity cost for local communities (Ferraro 2002). Avoided costs, however, are rarely 183 
estimated in CEA in conservation because these costs can be hard to judge accurately. Accurately 184 
estimating avoided costs requires good data on the effectiveness of an intervention, which can be 185 
lacking in conservation projects (Ferraro and Pattanayak 2006). The type of costs and avoided costs 186 
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(i.e., economic benefits) to be collected will also vary depending on the type of conservation 187 
intervention (see case study; Section 3.1).  188 
2.2. Elements of a robust economic evaluation 189 
Despite differences in the types of economic evaluation, there are certain things that all economic 190 
evaluations should consider and report. We discuss these in turn, providing examples from health 191 
care and conservation. First, a well-designed economic evaluation should clearly set out the context 192 
for the economic evaluation (Table 1; Questions 1-3) by stating the research question, and justifying 193 
the economic importance of the issue and rationale for the type of evaluation used in relation to the 194 
question being addressed (Drummond et al. 2005). The context for the evaluation describes the 195 
importance of the problem in terms of the economic burden it creates for society, which drives the 196 
need for the intervention (Table 1), such as illness reducing the productivity of the workforce, or 197 
deforestation causing landslides. Part of the economic context is also considering how investing in 198 
an intervention might influence future costs, both through avoided costs and indirectly creating 199 
additional costs (Table 1). The complex nature of indirect costs that can create perverse outcomes is 200 
a challenge in both conservation (e.g., impacts of pollution created by herbicide use), and medicine 201 
(e.g., river contamination by estrogenic compounds) as it requires a detailed understanding of 202 
system dynamics in conservation and close monitoring of side-effects in medicine. Finally, the 203 
economic context must also consider who will bear the costs and who will receive the benefits 204 
(Table 1). This is important for understanding equity issues surrounding interventions because the 205 
costs and benefits are often inequitably distributed across different stakeholders and locations 206 
(Guerrero et al. 2013), generally disproportionately impacting local communities (e.g., as in our case 207 
study; Gjertsen et al. 2014). 208 
Authors must also determine the appropriate spatial and temporal scale for the economic evaluation 209 
(Table 1; Questions 4, 5, 8, 9, 14, 15), because this has implications for the scale at which costs and 210 
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benefits need to be measured. For example, there can be economies of scale in implementing an 211 
intervention such that cost-effectiveness is greater at larger scales (Armsworth et al. 2011). Benefits 212 
can also vary spatially, sometimes occurring beyond the intervention site (Guerrero et al. 2016), such 213 
that small scale actions can have large scale benefits. Avoided costs generally occur on a different 214 
time horizon to the intervention costs; costs occurring early in the time horizon and benefits (or 215 
avoided costs) accruing later in the time horizon, thus making project evaluation very sensitive to 216 
the discount rate used (Cook et al. 2011). The appropriate scale of the economic evaluation depends 217 
on the context for the intervention (see section 2.3) and the purpose of the evaluation. For example, 218 
if the evaluation is being conducted by government they may not be interested in long-term 219 
outcomes, and so set the time horizon for costs and benefits at a political term. With an ecological 220 
outcome in mind, the time horizon could be decades (e.g., habitat restoration).  221 
Economic evaluations should consider a range of factors relating to the costs associated with an 222 
intervention (Table 1). Using broad categories of costs, including personnel (e.g., person-hours), 223 
equipment, materials, transportation, and capital costs (e.g., depreciation of machinery used) 224 
(Brunetti et al. 2013; Table 1; see template for costs in Table S1) can guide decisions about which 225 
costs to include. It is important that costs be disaggregated when they are reported (see Section 2.4). 226 
Using disaggregated values, an estimate of the total cost can be made along with a measure of the 227 
uncertainty associated with that estimate (Brunetti et al. 2013). However, economic evaluation is 228 
also trying to assess questions about which costs will be most influential in deciding to conduct an 229 
intervention (Table 1). For example, there may be relatively high fixed costs related to travel to a site, 230 
which will make any intervention costly (e.g., in our case study; Gjertsen et al. 2014). Similarly, it is 231 
important to consider whether the intervention was conducted in different ways that might 232 
influence the costs (Table 1). This might relate to the intensity (e.g., shooting pest animals from a 233 
helicopter versus a vehicle) or the approach (e.g., home care versus hospital treatment) to the 234 
intervention. These metadata about the intervention (see Section 2.3) are critical to interpreting the 235 
costs of the intervention and should be discussed in relation to the evaluation outcomes.  236 
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The quality of the outcome measures are critical to robust economic evaluations (Table 1). The 237 
source of effectiveness estimates should be detailed, describing the primary outcome measure and 238 
justifying the methods used to value benefits (Table 1; Shemilt et al. 2008). Studies should also 239 
provide details of any analyses or statistical tests conducted (Brunetti et al. 2013) such as effect sizes 240 
and their associated confidence intervals, and at a minimum report summary statistics (mean, 241 
sample size, variability) that enable effect sizes to be calculated (Haddaway 2015). 242 
When interpreting the findings of the study, there should be a discussion of what level of cost is 243 
likely to be meaningful to a decision maker when selecting an intervention. In the context of budget 244 
constraints, the cost of an intervention may be negligible or may make the intervention unaffordable. 245 
Likewise, some elements of the intervention may be responsible for the majority of the cost, such as 246 
for labour intensive methods (Table 1, Question 7), and highlighting the important components of 247 
the overall cost of an intervention allows decision makers to consider variants that may reduce costs 248 
(Table 1, Question 11). Wherever possible, there should be a consideration of the additional benefit 249 
needed to justify a more costly version of the intervention. This involves considering the relationship 250 
between the costs and the benefits of the intervention. Where there is a linear relationship between 251 
costs and benefits, it may be simple to determine how much to spend to achieve the desired 252 
outcome (Fig. 2). Alternatively, there may be a minimum level of investment to achieve any outcome 253 
at all, or small investments may generate large positive outcomes (Fig. 2). For instance, large 254 
nonlinearities occur in the case of invasive pest eradication by which only certified eradication would 255 
allow the cessation of control efforts, creating a spike in economic benefits (Fraser et al. 2006). 256 
Estimates of the uncertainty in the costs-benefit relationship are also critical to determining how 257 
reliable outcomes will be under different levels of investment (Table 2), and the probability that they 258 
will be fully realised over time. In our case study, uncertainty in parameter estimates for turtle 259 
population models are addressed through the use of probability distributions (Gjertsen et al. 2014). 260 
This is all valuable information for decision-makers trying to decide which intervention to adopt. 261 
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2.3. Metadata for an economic evaluation 262 
A challenge for economic evaluations is that costs can vary widely in different context. Therefore, 263 
metadata should be included that provide critical context for the evaluation (Table 2), facilitate the 264 
transfer of cost information among conservation interventions and enable evidence synthesis (see 265 
Section 3). The context for the intervention (e.g., starting conditions) and how it was conducted (i.e., 266 
details of the methodology for the intervention) yields valuable information about the intensity and 267 
approach used (Table 2) that can help interpret both the cost information and the outcome 268 
information. This should include the spatial and temporal scale for the intervention (Table 1, 269 
Question 4-5; Table 2). Interpreting the results of an economic evaluation also requires information 270 
about the time horizon over which the costs and outcomes were calculated (Table 2). For example, 271 
cost estimates may be substantially lower if only the cost of the initial treatment is included, rather 272 
than including on-going maintenance costs. Likewise, the outcomes could differ significantly if 273 
measured directly after the treatment, rather than one or two years later. This is typical of the 274 
economic evaluation of invasive species, where avoided costs can outweigh intervention costs as 275 
longer time horizons are considered (Cook et al. 2011). This may over-estimate benefits if outcomes 276 
are short-lived or under-estimate benefits if outcomes take decades to accrue (e.g. habitat 277 
restoration). Measuring short term outcomes provides no indication of whether outcomes continue 278 
to accrue over time. This is also true in health care, where studies rarely measure the longevity of 279 
outcomes (e.g., do subjects maintain weight loss?).  280 
While detailed reporting of the resources used is desirable through a standardised protocol such as 281 
that in Table S1, if resource use is recorded as the monetary cost, it is important to report the 282 
currency and the year of expenditure in the metadata (Table 2, Table S1). This will ensure figures can 283 
be translated into a common currency and price year through the use of conversion factors, such as 284 
purchasing power parity and gross domestic product deflators (Shemilt et al. 2008). The source of 285 
any cost estimates should also be included, describing any cost calculations or comparators used. 286 
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This information enables the findings of the economic evaluation to be interpreted in other 287 
jurisdictions. 288 
3. A tool for transparent reporting of intervention costs 289 
To facilitate robust and transparent recording and reporting of costs, we suggest the use of a 290 
standardised protocol that sets out the elements involved in the intervention and the opportunity 291 
costs (Table S1). This protocol is based on CostIt, a cost reporting tool for health interventions from 292 
the WHO (WHO 2015). An alternative specialized cost reporting tool for REDD+ projects is the REDD+ 293 
Cost Model (CIFOR 2016).  294 
This protocol not only prompts the evaluator to consider the important cost categories (see Section 295 
2.2; Table 1) and to disaggregate costs data, but also to include the generic units and unit costs. This 296 
is defined as the “ingredients approach” in the recommendations for CEA by the WHO (Edejer et al. 297 
2003). For instance, reporting the number of person hours and the salary per person hour, or litres 298 
of fuel and the unit cost per litre, rather than the aggregated monetary costs incurred during the 299 
study (Brunetti et al. 2013). This is important because reporting total costs, rather than the 300 
ingredients used to calculate those costs, prevents practitioners from transferring this information 301 
to other settings, or even evaluating how useful it is for their own case (Edejer et al. 2003). Similarly, 302 
it prevents understanding how costs will vary if the intervention effort is increased or decreased.  303 
3.1. Case study 304 
In Table S2, we illustrate the use of this tool based on a case study of an intervention to conserve 305 
Pacific turtle (Dermochelys coricea) in Hawaii, California and Indonesia (Gjertsen et al. 2014), which 306 
provided unusually detailed cost information. The intervention in Indonesia involved easily 307 
quantified capital costs (on-site camps to house personnel), transport costs to and from the camps 308 
and administration costs (IC in CER). Also included in the IC were the costs to compensate the 309 
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community for impacts on their livelihoods (i.e., the opportunity costs of stopping egg collection in 310 
Indonesia). The Hawaiian and Californian interventions involved fisheries closures and regulation 311 
and was costed based on the opportunity costs of changing equipment, and fisheries closure. The 312 
change in outcomes corresponded to the improvements in the turtle population (∆O), estimated 313 
through biological models which capture uncertainty in the estimated ecological benefits (Gjertsen 314 
et al. 2014; Table S2 in Supplementary material). The cost per turtle saved (CER) was then estimated.  315 
Unfortunately, the case study used to illustrate the protocol reported aggregated costs, making it 316 
difficult to determine how complete the costings were or how they would transfer to different 317 
regions or contexts (see Section 2.2). Nevertheless, it provides a useful example of the different 318 
types of costs, including the opportunity costs of an intervention (see Section 2.1), and the challenge 319 
for those wishing to interpreting the findings of economic evaluations that do not provide detailed 320 
metadata (Table 2) or disaggregated cost data and generic units. In addition, the authors 321 
acknowledged that the opportunity costs to local communities are not fully compensated in the 322 
program (Gjertsen et al. 2014), which highlights the need for studies to take note of any inequality in 323 
the distribution of costs and benefits among different stakeholders in a conservation intervention. 324 
Transparent reporting of costs, and who bears them, can help identify these inequities.  325 
4. Synthesizing data from economic evaluations 326 
Understanding the relationship between the costs and benefits of an intervention requires 327 
measuring both across the range of conditions in which the intervention is implemented, providing 328 
an understanding of the socioeconomic and environmental context. This is beyond the scope of 329 
most economic evaluations but can be established through meta-analysis where there are multiple 330 
economic evaluations addressing the application of the intervention under different conditions (e.g., 331 
Carrasco et al. 2014). While far from ubiquitous, economic evaluations of medical interventions are 332 
considerably more widespread than for conservation interventions; although, it is still rare for meta-333 
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analyses of CEA studies to account for the context of the intervention. Nevertheless, in health care 334 
economic evaluations are incorporated into evidence synthesis tools like systematic reviews, to 335 
determine which interventions provide the greatest return-on-investment under different 336 
circumstances (Drummond et al. 2005).  337 
4.1. Integrating economic data into systematic reviews 338 
The Cochrane Handbook for authors of systematic reviews of medical evidence provides explicit 339 
guidance for how to integrate the available data from existing economic evaluations into systematic 340 
reviews (Shemilt et al. 2008). These guidelines ensure that authors consider the relevant issues a 341 
priori and extract the necessary information from studies (Table 2) to properly consider the different 342 
factors that can influence the return-on-investment. 343 
One key lesson that can be learnt from systematic reviews of medical interventions is that 344 
integrating economic evaluations has implications for every step in the evidence synthesis process. 345 
While meta-analysis can be used to synthesize the results of multiple economic evaluations as part 346 
of a systematic review (Shemilt et al. 2008), costs should be fully integrated into the review process. 347 
That is, in the a priori protocol the objectives for how the cost data will be used within the review 348 
should be clear, there should be explicit reference to economic evaluations in the inclusion criteria 349 
for studies, the outcome measures to be used should be clear (and consistent to facilitate 350 
comparisons among studies) and there should be specific mention of the return-on-investment 351 
within the recommendations for management and further research (Shemilt et al. 2008). Providing 352 
guidelines for how costs should be discussed in relation to the implications for management and 353 
further research has enabled medical systematic reviews to be more consistent in the interpretation 354 
of review findings.  355 
Just as with other studies included in systematic reviews, it is important to assess the quality of 356 
economic evaluations. Economic evaluations should always include the relevant information about 357 
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how the study was conducted (e.g., the type of valuation method, the time horizon; Table 2) to 358 
enable this quality assessment (Section 2.3). However, it is important to note that inconsistent 359 
results between economic evaluations do not necessarily indicate poor quality studies. There can be 360 
legitimate reasons why costs vary between studies and this variability, once environmental and 361 
socioeconomic factors are accounted for, can provide valuable insight into different applications of 362 
the treatment. Therefore, it is worthwhile exploring the reasons behind any differences. If plausible 363 
reasons cannot be found for variation in cost estimates, then the confidence in those estimates 364 
should be reduced (Brunetti et al. 2013).  365 
Where multiple estimates of costs are available, any variation in cost estimates between economic 366 
evaluations should be explored. Some variation will be explained by how the intervention was 367 
conducted, which can help reveal the most cost-effective way to achieve the desired outcomes. For 368 
example, it would be possible to examine whether shooting feral goats from a helicopter versus 369 
doing it from a car provides sufficient benefits to justify the additional cost. Similarly, it is worth 370 
investigating which costs are most variable and why, and the relevant implication for the way 371 
interventions should be conducted. Where there is concern about the quality of some economic 372 
evaluations, sensitivity analysis can be used to determine the impact of potentially spurious studies 373 
on the overall findings. Sensitivity analyses can also be used to explore the stability of results, testing 374 
assumptions by including different components of costs, or altering which pieces of data are used in 375 
the analysis using alternative data and assumptions (Chee 2004).  376 
Sensitivity analyses can be valuable for exploring which costs are most influential in determining the 377 
overall cost of the intervention (Brunetti et al. 2013). Differences in cost will often be explained by 378 
variation in the location, timing and spatial and temporal scale of the study, which helps estimate 379 
how much costs differ for the same intervention. Therefore, information about the context for the 380 
intervention that might influence the heterogeneity of costs should be recorded (Table 2). The 381 
relevant contextual factors are often the same as those that influence the heterogeneity in 382 
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effectiveness of interventions. Highlighting large, unexplained discrepancies between studies can 383 
suggest areas for further research, and draw attention to the decision context where such 384 
knowledge gaps are most relevant. 385 
5. Recommendations for improving the use of economic evaluations in 386 
conservation 387 
For conservation, a significant challenge for integrating economic evidence into management 388 
recommendations is finding primary evidence on the costs of interventions. To evaluate the 389 
variability in costs and outcomes of interventions across the range of relevant management contexts, 390 
it is necessary to conduct economic evaluations under a range of conditions. Therefore, economic 391 
evaluations should be given an important place in the conservation literature, building a routine 392 
commitment to primary conservation research recording the costs associated with an intervention 393 
when effectiveness is being tested. A strong incentive for researchers to make this change would be 394 
a requirement by academic journals to report costs and associated metadata as supplementary 395 
material. To be most effective, agreed standards should be adopted for how to capture and report 396 
the costs of conservation projects. Without standards, the availability and quality of estimates of 397 
resource use are likely to remain poor, limiting the ability to conduct economic evaluations. While 398 
there may be sensitivities to transparently reporting costs (e.g., concerns about perceived 399 
competitiveness when tendering for grants), the reporting of raw units without the actual dollar 400 
figure would still provide valuable information for others, and granting bodies could require this in 401 
project outcomes reporting.  402 
Despite the challenges, capturing cost data should not be an all or nothing proposition, and it is 403 
important that tools for evidence synthesis, such as systematic reviews and evidence synopses, 404 
attempt to capture cost estimates wherever they are available. This may mean that initially cost 405 
estimates are simple, presented as relative figures (e.g., one intervention requires 3 to 5 times more 406 
resources than the alternative), and discussed broadly in terms of how and when the costs of an 407 
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intervention might alter the choices of decision-makers. In these cases, costs would not be 408 
incorporated into the critical review, but could be discussed qualitatively. Where this is done, it will 409 
be critical to include an analysis of why costs were difficult to estimate and the important sources of 410 
uncertainty in the available information. While far from the ideal evidence for decision-makers, such 411 
presentations may encourage discussion about how to improve estimates or the important factors 412 
to consider.  413 
6. Conclusions 414 
Economic evaluations that compare alternative interventions provide decision-makers with critical 415 
information about cost-effectiveness. Conservation is not the only discipline to face challenges in 416 
capturing and integrating information about intervention and opportunity costs into decisions-417 
making, enabling us to leverage progress made elsewhere. Examples from health care illustrate the 418 
value of developing universally agreed outcome measures that enable comparison between 419 
interventions targeted at different outcomes, and the benefit of including avoided costs when 420 
calculating cost-effectiveness ratios. Moving forward as a discipline requires widespread recognition 421 
of the benefits of considering the costs of management, a commitment from researchers to capture 422 
economic information, clear guidelines and standards for how to capture and report these data in a 423 
standardized manner, and real incentives for conducting economic evaluations of management 424 
interventions. We acknowledge however that systematically collecting cost and effectiveness data is 425 
challenging and even simple qualitative accounts would prove very valuable to advance the field. 426 
Practitioners should not be discouraged from collecting cost data if a full detailed report is not 427 
feasible. We attempt to advance the systematic reporting of costs by developing several cost 428 
reporting tools for conservation interventions (Tables 1, 2, S1). As the knowledge base grows, 429 
economic evaluations should be routinely integrated into methods for evidence synthesis and used 430 
to help practitioners make rational decisions about resource allocation. While the necessary changes 431 
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will require effort, researchers may find that their science gets greater traction with decision-makers 432 
if research findings can be communicated in terms of the greatest return on investment.  433 
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Tables and Figure Legends 
Table 1. Important elements of economic evaluations of interventions and questions to facilitate the economic analysis and reporting for health care versus 
conservation interventions [adapted from Shemilt et al. 2008]. 
 Examples from health care Examples from conservation 
Economic Context 
Question 1.   What is the economic burden to society of the problem the intervention is seeking to affect and what proportion of that burden can be reduced 
by the intervention? 
 Smoking cessation would reduce the economic burden on the public 
health system of the health problems associated with smoking.  
Illness leads to reduction in productivity due to patients requiring time out 
of the work force. 
Environmental weeds have costs to landholders and governments in 
terms of lost productivity and management costs. 
Weeds can disrupt ecological processes leading to additional 
management costs (e.g., fire management due to gamba grass 
infestations in Northern Australia increasing the frequency of wildfires; 
Settlerfield et al. 2014). 
Question 2.   How might investing in the intervention influence future resource use? 
 Intervening may lead to indirect costs associated with the treatment (e.g., 
the need to manage side-effects from a treatment). 
 
Early intervention programs can reduce the cost of co-morbidity (e.g., 
reducing childhood obesity can reduce the incidence of type 2 diabetes). 
Intervening may lead to indirect costs associated with the action (e.g., 
costs of managing changes in water quality caused by herbicide 
application or soil disturbance caused by mechanical removal). 
Intervening may lead to changes in recurrent costs (e.g., reduction in 
cost of on-going management due to local eradication of a weed versus 
the increased cost of management if inaction allows the weed to spread 
into new areas). 
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Question 3.   How equitably will the costs and benefits of the intervention be distributed? 
 Government (therefore society) often pay for health care interventions 
while benefits primarily accrue to treated individuals and employers 
(through increased productivity). 
The costs of interventions such as fisheries closures can be incurred by 
conservation agencies but also cost local communities their livelihoods. 
Unless compensation is paid to local communities, benefits will accrue 
to society generally at the expense of local communities. 
Intervention Context 
Question 4.   What is the spatial scale of the intervention? 
 The spatial scale of an intervention can have impact costs in two ways. 
First the overall scale could be local (e.g., bednets for a village), regional 
(e.g., health care education program), national or international (e.g., 
immunization program).  
Second, how dispersed the treatment locations are could reduce 
economies of scale due to extra travel time between sites. For example, 
treating several villages in a region that is sparsely populated. 
The spatial scale of an intervention can have impact costs in two ways. 
First the overall scale could be local (e.g., protect a single population of 
threatened species), regional (e.g., landscape scale restoration), 
national or international (e.g., illegal wildlife trade)  
Second, how dispersed the treatment locations are could reduce 
economies of scale due to extra travel time between sites. For example, 
treating 5 ha in a single plot versus 5, 1 ha plots. 
Question 5.   What is the temporal scale of the intervention? 
 Costs can vary significantly with the temporal scale of an intervention. A 
treatment could be short term over days (e.g., contraceptive implant), 
multiple treatments over months (e.g., chemotherapy) or long-term 
treatment program over years (e.g., major surgery and rehabilitation).  
Costs can vary significantly with the temporal scale of an intervention. A 
treatment could be short term over days (e.g., fishery closure), multiple 
treatments over months (e.g., weed management) or long-term 
treatment program (e.g., rat eradication from island with on-going 
surveillance). 
   
Question 6.   What is the starting condition (state) for the intervention? 
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 The cost of an intervention for individuals with a chronic illness that has 
caused organ damage could be significantly higher than an early 
intervention program before illness becomes chronic. 
Cost will be significantly higher at a site where weeds are established 
and at high densities versus a site where the native vegetation is largely 
intact and weeds are localised. 
Costs 
Question 7.   What resources are required to implement and sustain the intervention? 
 Categories of resources include personnel (e.g., specialists, clinicians, 
nurses, laboratory technicians), intervention costs (e.g., drugs, surgery, 
physical therapy), laboratory tests, transportation costs (e.g., patient 
transport, home visits), capital costs (e.g., constructing a temporary clinic) 
Categories of resources include personnel (e.g., field workers, 
laboratory technicians, training), equipment (e.g., tools, safety gear), 
consumables (e.g., herbicide), transportation costs (e.g., travel to and 
from the site), capital costs (e.g., building camps) (Table S1). 
Question 8.   What is the time horizon over which costs are likely to accrue? 
 Costs may be immediate and one off (e.g., surgery) or interventions may 
continue over a number of years (e.g., physical therapy to recover from 
stroke).  
Costs may be accrued once or over several years depending on the 
treatment. For example, a single herbicide application may be used or 
repeated applications may be required followed by revegetation.  
Question 9.   What is the spatial scale over which costs are likely to occur? 
 The costs may be incurred at multiple scales, including a broad scale for 
government funded programs (e.g., by society as a whole), or local scale 
for user pays schemes (e.g., by the patient) or combination of scales when 
costs are shared among a range of stakeholders (e.g., community run 
education programs, combined with government treatment programs). 
The costs may be incurred at multiple scales, including broad scale for 
government funded programs (e.g., by society as a whole), 
intermediate scale (e.g., donors to NGOs) or local scale (e.g., regulation 
affecting private landholders) or a mixture of all of these. 
Question 10.   Who will incur the costs of the intervention? 
 The costs may be incurred by society as a whole (e.g., government funded 
programs), the patient (e.g., user pays) or a mixture of both. 
Costs can be incurred by society as a whole (e.g., government 
programs), stakeholders (e.g., landholders, NGOs), communities (e.g., 
27 
 
 Examples from health care Examples from conservation 
livelihood impacts of opportunity costs) or a combination of these. 
Question 11.   Which costs are likely to be most important in deciding to carry out the intervention? 
 Generally there are some elements of medical interventions that are 
always costly and will influence whether the intervention is affordable 
(e.g., surgery, hospital stays, the need for on-going care). 
Labour costs are often significant and may influence the practicality of 
some interventions. Project may require specialist skills not available in-
house adding costs for contractors or staff training. Likewise, 
opportunity costs may be large if the project affects land use. 
Question 12.   What are the costs of different variants of the intervention? 
 Different ways of administering the intervention might include a lower 
dose of medication or fewer applications. These variants might have 
different objectives, such as managing chronic illness rather than providing 
a cure. 
Different intensities of an intervention (e.g., single versus multiple 
applications of herbicide, increased concentrations of the herbicide). 
These variants might represent different management objectives of 
containment versus eradication. 
Outcomes 
Question 13.   What is the best measure of the outcomes of the intervention? 
 The primary outcome measure for an intervention aimed at reducing 
blood pressure may be the number of heart attacks avoided. Complex 
outcomes might be measured as Quality Adjusted Life Years or Disability 
Adjusted Life Years. 
The primary outcome measure for a weed management intervention 
could be the restoration of native vegetation. Other outcomes might be 
the number of threatened species that have been protected from 
extinction.  
Question 14.   What is the time horizon over which outcomes are likely to accrue? 
 Outcomes might be rapid (e.g., patients who would have died survive) but 
may only accrue over long time periods (e.g., rehabilitation from a 
Outcomes may be accrued rapidly (e.g., increased survival and 
reproduction) or may take decades to accrue (e.g., habitat restoration). 
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 Examples from health care Examples from conservation 
traumatic brain injury). 
Question 15.   What is the spatial scale over which outcomes are likely to accrue? 
 Outcomes might be rapid (e.g., patients who would have died survive) but 
may only accrue over long time periods (e.g., rehabilitation from a 
traumatic brain injury). 
Outcomes may be accrued rapidly (e.g., increased survival and 
reproduction) or may take decades to accrue (e.g., habitat restoration). 
Question 16.   Who will benefit from the intervention? 
 Benefits can be local (e.g., the individual treated), regional (e.g., state 
government programs benefiting taxpayers and employers in the state) or 
broad scale accrued by society as a whole (e.g., laws preventing passive 
smoking). 
Benefits may also accrue in a different location to where costs are incurred 
(e.g., immunization programs that prevent the spread of disease to 
surrounding areas) 
Benefits can be accrued locally (e.g., human-wildlife conflict 
interventions), regionally (e.g., restoration of ecosystem services) or 
more broadly for species conservation (e.g., accounting for intrinsic 
value of threatened species).  
Benefits may also accrue in a different location to where costs are 
incurred (e.g., for migratory species that move across borders). 
a Can be viewed as avoided costs if an intervention is successful  
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Table 2. The metadata that should be reported in studies to facilitate evidence synthesis. 
Item Description Relevance 
Context 
Date The year the study was 
conducted and dates when 
the costs were incurred if 
different. 
Used to convert monetary figures to 
common price year 
Study location The geographical location of 
the study 
Used to examine whether geographic 
location influences the cost of the 
intervention 
Context for the 
intervention 
Description of the starting 
conditions for an intervention 
(e.g., initial population size or 
area affected, environmental 
conditions, histories of human 
disturbance etc) 
Provides critical detail for understanding 
both the expected benefits for an 
intervention and the resource required to 
achieve the desired outcome. 
Methodological information 
Study design Detail about how the study 
was conducted 
Used to determine whether the findings 
of the study are sufficiently reliable to be 
included in the review 
Details of the 
interventions 
Specific details about how 
each intervention was carried 
out 
Used to determine whether all resources 
used have been accounted for and to 
examine variability in costs and outcomes 
Estimates of 
effectiveness 
The measure of the outcomes 
derived from the intervention 
Allows the outcomes of different 
interventions and different studies to be 
compared alongside the data on costs 
Time horizon for 
outcomes 
The total period of time over 
which outcomes will accrue 
This is relevant when outcomes are 
uncertain or may accrue over a long 
period of time (e.g., restoration projects). 
Benefits or 
avoided costs 
Benefits derived from the 
intervention (e.g. ecosystem 
services provided) 
Needed to deduct from the intervention 
and opportunity costs. They may offset a 




Item Description Relevance 
Time horizon for 
benefits or avoided 
costs. 
The flow of benefits across the 
time horizon. 
Needed to understand how the time 
horizon affects the CEA. 
Economic information 
Resources used The amount of natural units 
and unit cost of resources 
used under different 
categories (Table S1) 
Used to estimate the overall cost of the 
intervention. Reporting the units or 
values for each resource used allows the 
variability in costs between interventions 
and between studies to be compared, 
and facilitates sensitivity analysis to 
determine which costs are most 
influential. 
Currency The currency in which 
monetary costs were paid 
Used to convert monetary figures to 
common price year 
Source of data for 
resources used 
A description of how each of 
the resources were measured 
and any cost calculations or 
comparators used to derive 
these values  
Assists in converting different cost 
estimates into the same price year, and 
facilitates exploration of variation 
between cost estimates. 
Time horizon for 
costs 
The total period of time over 
which costs were incurred 
This information is needed to compare 
the cost and outcomes of interventions 
over time (e.g., when not all costs are 
incurred up front or where effectiveness 
is related to the number of repeated 
applications of an intervention).  
Uncertainty in cost 
estimates 
A description of any sources of 
uncertainty in the estimates of 
resource use provided by 
authors 
Provides guidance about how complete 
estimates are likely to be, and can be 
used to develop confidence intervals 






Figure 1. The number of studies in the conservation literature that include the keywords 
“effectiveness” (solid line) and “cost-effectiveness” (broken line) over the past 20 years. Blue bars 
indicate the proportion of studies considering cost-effectiveness relative to the overall number 
considering effectiveness, demonstrating that any increase in number is likely a product of 







Figure 2. Four examples of the relationships between intervention costs and conservation outcomes 
for alternative interventions (solid black line = intervention 1; solid grey line = intervention 2). The 
broken lines represent the cost of implementing each alternative intervention to achieve the desired 
conservation outcomes. (a) Both relationships are linear but the gradient determines the best 
alternative. (b) While conservation outcomes are acquired rapidly for relatively little cost, marginal 
decreasing returns occur and, as a result, intervention 1 never achieves the desired conservation 
outcomes. (c) Both interventions require a significant investment to accrue conservation outcomes. 
(d) The best intervention changes beyond a certain level of investment. 
 
View publication stats
